The systematic review data on the inflammatory gene expression in circulating leukocytes confirmed this phenomenon, showing that patients with a high gene expression level of IL1β, TNF, and/or MIF did not respond well to interventions with an SSRI in comparison to MDD patients with a low expression of these genes. This evidence concerns the gene IL1B and major depressive disorder.